Compile Data Set for Download or QSAR
maximum 50k data
Found 45 with Last Name = 'lameh' and Initial = 'j'
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50232153((1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethox...)
Affinity DataKi:  0.0300nM ΔG°:  -55.8kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM139371(eplivanserin)
Affinity DataKi:  0.0460nM ΔG°:  -54.8kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50001775((ritanserin)6-(2-{4-[Bis-(4-fluoro-phenyl)-methyle...)
Affinity DataKi:  0.0830nM ΔG°:  -53.5kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Molecular Research Institute

Curated by PDSP Ki Database
LigandPNGBDBM86056(CAS_156889 | NSC_156889 | Xorphanol)
Affinity DataKi:  0.25nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50001775((ritanserin)6-(2-{4-[Bis-(4-fluoro-phenyl)-methyle...)
Affinity DataKi:  0.440nM ΔG°:  -49.6kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM139370(ACP-103 | Nuplazid | Pimavanserin | Pimavanserin h...)
Affinity DataKi:  0.5nM ΔG°:  -49.3kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM22869(6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatric...)
Affinity DataKi:  0.550nM ΔG°:  -49.1kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Molecular Research Institute

Curated by PDSP Ki Database
LigandPNGBDBM50000787((1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydr...)
Affinity DataKi:  0.740nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMedDrugBank

TargetMu-type opioid receptor(Homo sapiens (Human))
Molecular Research Institute

Curated by PDSP Ki Database
LigandPNGBDBM85331(CAS_115077 | NSC_115077 | WIN 44,441(-))
Affinity DataKi:  0.990nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Molecular Research Institute

Curated by PDSP Ki Database
LigandPNGBDBM50001031(3-Allyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-me...)
Affinity DataKi:  1.15nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM22869(6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatric...)
Affinity DataKi:  1.30nM ΔG°:  -47.1kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM139371(eplivanserin)
Affinity DataKi:  1.30nM ΔG°:  -47.1kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM139370(ACP-103 | Nuplazid | Pimavanserin | Pimavanserin h...)
Affinity DataKi:  1.60nM ΔG°:  -46.7kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetMu-type opioid receptor(Homo sapiens (Human))
Molecular Research Institute

Curated by PDSP Ki Database
LigandPNGBDBM50000092((-)-(etorphine) | (-)-morphine | (1S,5R,13R,14S)-1...)
Affinity DataKi:  2.20nMMore data for this Ligand-Target Pair
TargetMu-type opioid receptor(Homo sapiens (Human))
Molecular Research Institute

Curated by PDSP Ki Database
LigandPNGBDBM21015((2S)-2-{2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl...)
Affinity DataKi:  2.65nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50232153((1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethox...)
Affinity DataKi:  3.80nM ΔG°:  -44.7kJ/moleT: 2°CAssay Description:For the membrane binding, NIH-3T3 cells were grown to 70% confluence in 15-cm2 dishes and transfected with 10 ug of receptor plasmid DNA using Polyfe...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50001775((ritanserin)6-(2-{4-[Bis-(4-fluoro-phenyl)-methyle...)
Affinity DataIC50:  0.0690nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM139371(eplivanserin)
Affinity DataIC50:  1nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50232153((1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethox...)
Affinity DataIC50:  1.10nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM139370(ACP-103 | Nuplazid | Pimavanserin | Pimavanserin h...)
Affinity DataIC50:  1.90nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50001775((ritanserin)6-(2-{4-[Bis-(4-fluoro-phenyl)-methyle...)
Affinity DataIC50:  3nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50001775((ritanserin)6-(2-{4-[Bis-(4-fluoro-phenyl)-methyle...)
Affinity DataIC50:  4.5nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2A(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM22869(6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatric...)
Affinity DataIC50:  13nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM139370(ACP-103 | Nuplazid | Pimavanserin | Pimavanserin h...)
Affinity DataIC50:  91nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM22869(6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatric...)
Affinity DataIC50:  100nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM22869(6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatric...)
Affinity DataIC50:  200nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Target5-hydroxytryptamine receptor 2C(Homo sapiens (Human))
Acadia Pharmaceuticals

LigandPNGBDBM50232153((1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethox...)
Affinity DataIC50:  540nMAssay Description:R-SAT assays were performed as described previously (Weiner et al., 2001), with the following modifications. In brief, NIH-3T3 cells were grown to 80...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 1(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414854(CHEMBL574565)
Affinity DataEC50:  39.8nMAssay Description:Agonist activity at human NPFF1 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414855(CHEMBL573518)
Affinity DataEC50:  158nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 1(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414855(CHEMBL573518)
Affinity DataEC50:  126nMAssay Description:Agonist activity at human NPFF1 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414856(CHEMBL573519)
Affinity DataEC50:  126nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414854(CHEMBL574565)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 1(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414853(CHEMBL572825)
Affinity DataEC50:  158nMAssay Description:Agonist activity at human NPFF1 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414853(CHEMBL572825)
Affinity DataEC50:  200nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 1(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414852(CHEMBL573738)
Affinity DataEC50:  79.4nMAssay Description:Agonist activity at human NPFF1 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414852(CHEMBL573738)
Affinity DataEC50:  100nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414851(CHEMBL574353)
Affinity DataEC50:  398nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 1(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414850(CHEMBL575058)
Affinity DataEC50:  794nMAssay Description:Agonist activity at human NPFF1 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414850(CHEMBL575058)
Affinity DataEC50:  794nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414849(CHEMBL572766)
Affinity DataEC50:  501nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 1(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50394977(CHEMBL583068)
Affinity DataEC50: >3.16E+3nMAssay Description:Agonist activity at human NPFF1 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50394978(CHEMBL573297)
Affinity DataEC50:  1.26E+3nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414848(CHEMBL572531)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 1(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50414856(CHEMBL573519)
Affinity DataEC50:  316nMAssay Description:Agonist activity at human NPFF1 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetNeuropeptide FF receptor 2(Homo sapiens (Human))
Acadia Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50394977(CHEMBL583068)
Affinity DataEC50:  501nMAssay Description:Agonist activity at human NPFF2 receptor expressed in cells assessed as beta-galactosidase levels after 5 daysMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed